FTDI
First Trust Direct Indexing’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,213
| Closed | -$235K | – | 105 |
|
|
2024
Q3 | $235K | Sell |
1,213
-1,533
| -56% | -$297K | 0.01% | 851 |
|
|
2024
Q2 | $637K | Buy |
2,746
+1,006
| +58% | +$233K | 0.04% | 437 |
|
|
2024
Q1 | $375K | Sell |
1,740
-101
| -5% | -$21.8K | 0.03% | 553 |
|
|
2023
Q4 | $476K | Buy |
1,841
+167
| +10% | +$43.2K | 0.04% | 453 |
|
|
2023
Q3 | $430K | Sell |
1,674
-250
| -13% | -$64.3K | 0.05% | 431 |
|
|
2023
Q2 | $548K | Buy |
1,924
+146
| +8% | +$41.6K | 0.06% | 387 |
|
|
2023
Q1 | $494K | Buy |
1,778
+18
| +1% | +$5.01K | 0.06% | 402 |
|
|
2022
Q4 | $487K | Buy |
1,760
+388
| +28% | +$107K | 0.06% | 389 |
|
|
2022
Q3 | $366K | Buy |
1,372
+114
| +9% | +$30.4K | 0.05% | 418 |
|
|
2022
Q2 | $257K | Buy |
1,258
+31
| +3% | +$6.33K | 0.04% | 519 |
|
|
2022
Q1 | $258K | Buy |
1,227
+100
| +9% | +$21K | 0.03% | 548 |
|
|
2021
Q4 | $270K | Sell |
1,127
-119
| -10% | -$28.5K | 0.04% | 521 |
|
|
2021
Q3 | $353K | Buy |
1,246
+200
| +19% | +$56.7K | 0.05% | 432 |
|
|
2021
Q2 | $362K | Sell |
1,046
-464
| -31% | -$161K | 0.05% | 416 |
|
|
2021
Q1 | $422K | Buy |
1,510
+126
| +9% | +$35.2K | 0.11% | 249 |
|
|
2020
Q4 | $339K | Buy |
+1,384
| New | +$339K | 0.09% | 272 |
|